APA (7th ed.) Citation

RS, R., SS, D., R, G., X, W., MB, N., & JS, F. (2022). Mycobacterium tuberculosis KasA as a drug target: Structure-based inhibitor design. Frontiers in cellular and infection microbiology, 12, 1008213. https://doi.org/10.3389/fcimb.2022.1008213

Chicago Style (17th ed.) Citation

RS, Rudraraju, Daher SS, Gallardo-Macias R, Wang X, Neiditch MB, and Freundlich JS. "Mycobacterium Tuberculosis KasA as a Drug Target: Structure-based Inhibitor Design." Frontiers in Cellular and Infection Microbiology 12 (2022): 1008213. https://doi.org/10.3389/fcimb.2022.1008213.

MLA (9th ed.) Citation

RS, Rudraraju, et al. "Mycobacterium Tuberculosis KasA as a Drug Target: Structure-based Inhibitor Design." Frontiers in Cellular and Infection Microbiology, vol. 12, 2022, p. 1008213, https://doi.org/10.3389/fcimb.2022.1008213.